Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging

NCT02916719 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT02916719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02916719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging
Lead sponsor
Brugmann University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 21, 2016
Completion date
March 3, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer